CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Vortioxetine

Last Updated: October 31, 2014
Result type: Reports
Project Number: SR0402-000
Product Line: Reimbursement Review

Generic Name: Vortioxetine

Brand Name: Trintellix

Manufacturer: Lundbeck Canada Inc.

Therapeutic Area: Depression, major depressive disorder

Indications: Depression, Major Depressive Disorder (MDD)

Submission Type: Initial

Project Status: Withdrawn